GCC Medical Evidence Generation Head

GCC Medical Evidence Generation Head

AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines for some of the world's most serious diseases. But we're more than one of the world's leading pharmaceutical companies.

Join a high-performing team, empowered to cut through the noise and drive real change. Our agility and pace, coupled with scientific focus, powers us to spot opportunities in the market that keep us moving forward and into new spaces.

AstraZeneca is experiencing a significant transformation in the Kingdom of Saudi Arabia, driven by a commitment to advancing healthcare, innovation, and sustainable growth. Building on our global legacy, AZ KSA is rapidly evolving its operations to better serve patients, collaborate with healthcare stakeholders, and contribute to the ambitious goals outlined in the Saudi Vision 2030. We are investing in talent, digital solutions, and new ways of working;

all designed to enhance our impact on patient outcomes and reinforce our leadership in therapeutic areas. This dynamic environment calls for visionary, agile professionals who thrive in change and are motivated to help shape the future of healthcare in KSA.

Associate Director, Head of Medical Evidence Generation (HMEG) leads and oversees Medical Evidence generation activities in AstraZeneca GCC Cluster and Pakistan to demonstrate scientific, medical and payer value related to AstraZeneca brands and business.

The role aims to support Access, Value, Policy & Practice changing activities aligned with GCC’s 2030 Vision by delivering local evidence through implementation of innovative data solutions, including leading on local data partnerships with external stakeholders, utilizing novel analytical tools, platforms, local and cluster healthcare data.

• The HMEG act as Team Leader of the GCC Medical Evidence Generation Team (Line management responsibility).
• The HMEG is accountable for the GCC Cluster’s all local research deliveries including scientific and strategic aspects, as well as budget.
• The HMEG oversees the continuous and optimal collaboration with SM&M and GMA/GMD, MEA/International Evidence teams aiming to contribute building a strong R&D footprint in GCC and position AZ GCC as recognized Scientific and Research leader.
• The HMEG has a key strategic role in driving evidence needs assessment for pre-launch assets (Value teams), GCC RWE concept development, RWE data generation and utilization to meet GCC medical and payer evidence needs.
• The HMEG will lead the operational planning, delivery, oversight, and budget management of company sponsored evidence studies and/or EAPs across all therapeutic areas (TAs). This person is responsible for leading a cross-functional AstraZeneca (AZ) study team and monitoring the CROs/ SMOs study team as well as for providing the teams with direction and guidance to enable operational excellence, successful study and/or EAP delivery.
• The HMEG is responsible to Identify, evaluate, and obtain high-quality Real-World Data (RWD) sources to support strategic decision-making. Assess the feasibility of data sources to ensure they align with research objectives and compliance requirements.
• The HMEG is responsible to design, conduct, and oversee evidence generation activities and RWD studies to expand the understanding of healthcare practices. Collaborate with cross-functional teams to disseminate findings that support local and global healthcare initiatives.
• The HMEG is responsible to analyse and interpret data to create compelling narratives that highlight practice-changing evidence. Effectively communicate insights to key stakeholders, including healthcare professionals, policymakers, and industry leaders, to influence clinical practices and drive healthcare improvements.
• The HMEG is also accountable for the GCC contribution to Externally Sponsored Research (ESR), including alignment with Therapeutic Area strategic needs as well as with regulations and AstraZeneca Standard Operating Procedures
• The HMEG oversees development of…